128 related articles for article (PubMed ID: 37995896)
1. Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho.
Liu M; Zhang Y; Zhan P; Sun W; Dong C; Liu X; Yang Y; Wang X; Xie Y; Gao C; Hu H; Shi B; Wang Z; Guo C; Yi F
Pharmacol Res; 2023 Dec; 198():107009. PubMed ID: 37995896
[TBL] [Abstract][Full Text] [Related]
2. Novel role of NOD2 in mediating Ca2+ signaling: evidence from NOD2-regulated podocyte TRPC6 channels in hyperhomocysteinemia.
Han H; Wang Y; Li X; Wang PA; Wei X; Liang W; Ding G; Yu X; Bao C; Zhang Y; Wang Z; Yi F
Hypertension; 2013 Sep; 62(3):506-11. PubMed ID: 23856489
[TBL] [Abstract][Full Text] [Related]
3. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
[TBL] [Abstract][Full Text] [Related]
5. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.
Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL
Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887
[TBL] [Abstract][Full Text] [Related]
6. Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.
Li C; Xia M; Abais JM; Liu X; Li N; Boini KM; Li PL
Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):551-61. PubMed ID: 23529346
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.
Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL
Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593
[TBL] [Abstract][Full Text] [Related]
8. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
Abais JM; Xia M; Li G; Gehr TW; Boini KM; Li PL
Free Radic Biol Med; 2014 Feb; 67():211-20. PubMed ID: 24140862
[TBL] [Abstract][Full Text] [Related]
9. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
[TBL] [Abstract][Full Text] [Related]
11. Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase.
Boini KM; Xia M; Abais JM; Xu M; Li CX; Li PL
PLoS One; 2012; 7(9):e45020. PubMed ID: 23024785
[TBL] [Abstract][Full Text] [Related]
12. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats.
Yi F; dos Santos EA; Xia M; Chen QZ; Li PL; Li N
Am J Nephrol; 2007; 27(3):262-8. PubMed ID: 17396029
[TBL] [Abstract][Full Text] [Related]
13. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Progranulin in Hyperhomocysteinemia-Induced Cardiorenal Dysfunction.
Fu Y; Sun Y; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Su Z; Liang K; Tang W; Yi F
Hypertension; 2017 Feb; 69(2):259-266. PubMed ID: 27872232
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
16. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.
Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F
Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296
[TBL] [Abstract][Full Text] [Related]
18. HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference.
Bourgeois CT; Satou R; Prieto MC
Biol Sex Differ; 2017; 8():18. PubMed ID: 28572913
[TBL] [Abstract][Full Text] [Related]
19. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes.
Zhang C; Hu JJ; Xia M; Boini KM; Brimson C; Li PL
Biochim Biophys Acta; 2010 Apr; 1803(4):482-91. PubMed ID: 20036696
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.
Xia M; Conley SM; Li G; Li PL; Boini KM
Cell Physiol Biochem; 2014; 34(3):829-41. PubMed ID: 25171193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
